Aktiesnakken — Oktober 2010
-
nej....de kan ikke løbe tør for cash længere
-
now worries - vi har en mulitpronged approach to build new revenue streams
-
den 9. november...
-
hahaha varnæs..i like you because you remember
-
ikke mange colombuss og det er noget genmab selv kan styre 100%
-
jeg kan mærke mit blodtryk stige, hver gang jeg hører det
-
de omlægger jo hele biksen til at blive mere work for hire og ikke så meget "I want to be pharma"
-
hvis jeg ellers forstår det David og Jan siger, så bliver det et helt andet setup i fremtiden
-
kurs 75 banker
-
har jeg lige læst
-
det jeg mener I allesammen undervurderer i Genmab, det er at det var usikkerheden der har fået den herned. Jan fjerner alt usikkerhed, så
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind